Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
International Journal of Molecular Sciences
|
August 14, 2025
The Pharmacokinetic and Pharmacodynamic Relationship of Clinically Used Antiseizure Medications in the Maximal Electroshock Seizure Model in Rodents
Luis Bettio, Girish Bankar, Celine M Dubé, et al.
JHEP Reports : Innovation in Hepatology
|
December 3, 2024
Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis
Connie Chan, Mateus Lemos, Peter Finnegan, et al.
Hepatology Communications
|
May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Bioorganic & Medicinal Chemistry
|
November 12, 2013
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice
Shaoyi Sun, Richard Dean, Qi Jia, et al.
The Lancet Regional Health. Western Pacific
|
August 24, 2021
COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study
Trung Nguyen, Mehnaz Adnan, Binh P Nguyen, et al.
Clinical Chemistry and Laboratory Medicine
|
July 10, 2007
Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?"
Adrián Llerena, Gerd Michel, Elise Jeannesson, et al.
ACS Chemical Neuroscience
|
February 15, 2024
Molecular Pharmacology of Selective Na<sub>V</sub>1.6 and Dual Na<sub>V</sub>1.6/Na<sub>V</sub>1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo
Samuel J Goodchild, Noah Gregory Shuart, Aaron D Williams, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 4, 2024
Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity
Hannah Bloemen, Alexandra E Livanos, Adrielly Martins, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2021
Identification of aryl sulfonamides as novel and potent inhibitors of Na<sub>V</sub>1.5
Shaoyi Sun, Qi Jia, Alla Y Zenova, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis
Adrielly Martins, Anish Reddy, Richard Dean, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
International Journal of Molecular Sciences
|
August 14, 2025
The Pharmacokinetic and Pharmacodynamic Relationship of Clinically Used Antiseizure Medications in the Maximal Electroshock Seizure Model in Rodents
Luis Bettio, Girish Bankar, Celine M Dubé, et al.
JHEP Reports : Innovation in Hepatology
|
December 3, 2024
Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis
Connie Chan, Mateus Lemos, Peter Finnegan, et al.
Hepatology Communications
|
May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Bioorganic & Medicinal Chemistry
|
November 12, 2013
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice
Shaoyi Sun, Richard Dean, Qi Jia, et al.
The Lancet Regional Health. Western Pacific
|
August 24, 2021
COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study
Trung Nguyen, Mehnaz Adnan, Binh P Nguyen, et al.
Clinical Chemistry and Laboratory Medicine
|
July 10, 2007
Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?"
Adrián Llerena, Gerd Michel, Elise Jeannesson, et al.
ACS Chemical Neuroscience
|
February 15, 2024
Molecular Pharmacology of Selective Na<sub>V</sub>1.6 and Dual Na<sub>V</sub>1.6/Na<sub>V</sub>1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo
Samuel J Goodchild, Noah Gregory Shuart, Aaron D Williams, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 4, 2024
Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity
Hannah Bloemen, Alexandra E Livanos, Adrielly Martins, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2021
Identification of aryl sulfonamides as novel and potent inhibitors of Na<sub>V</sub>1.5
Shaoyi Sun, Qi Jia, Alla Y Zenova, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis
Adrielly Martins, Anish Reddy, Richard Dean, et al.
Page
of 3